Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Patterns of Multimorbidity and Risk of Severe SARS-CoV-2 Infection: an observational study in the U.K

View ORCID ProfileYogini V Chudasama, View ORCID ProfileFrancesco Zaccardi, View ORCID ProfileClare L Gillies, View ORCID ProfileCameron Razieh, View ORCID ProfileThomas Yates, View ORCID ProfileDavid E Kloecker, View ORCID ProfileAlex V Rowlands, View ORCID ProfileMelanie J Davies, View ORCID ProfileNazrul Islam, View ORCID ProfileSamuel Seidu, View ORCID ProfileNita G Forouhi, View ORCID ProfileKamlesh Khunti
doi: https://doi.org/10.1101/2020.10.21.20216721
Yogini V Chudasama
1Leicester Real World Evidence Unit, Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yogini V Chudasama
  • For correspondence: yc244@leicester.ac.uk
Francesco Zaccardi
1Leicester Real World Evidence Unit, Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Francesco Zaccardi
Clare L Gillies
1Leicester Real World Evidence Unit, Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Clare L Gillies
Cameron Razieh
2NIHR Leicester Biomedical Research Centre, Leicester Diabetes Centre, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cameron Razieh
Thomas Yates
2NIHR Leicester Biomedical Research Centre, Leicester Diabetes Centre, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas Yates
David E Kloecker
1Leicester Real World Evidence Unit, Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David E Kloecker
Alex V Rowlands
2NIHR Leicester Biomedical Research Centre, Leicester Diabetes Centre, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alex V Rowlands
Melanie J Davies
2NIHR Leicester Biomedical Research Centre, Leicester Diabetes Centre, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Melanie J Davies
Nazrul Islam
3Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK
4Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nazrul Islam
Samuel Seidu
1Leicester Real World Evidence Unit, Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Samuel Seidu
Nita G Forouhi
4Medical Research Council Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nita G Forouhi
Kamlesh Khunti
1Leicester Real World Evidence Unit, Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kamlesh Khunti
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Pre-existing comorbidities have been linked to SARS-CoV-2 infection but evidence is sparse on the importance and pattern of multimorbidity (2 or more conditions) and severity of infection indicated by hospitalisation or mortality. We aimed to use a multimorbidity index developed specifically for COVID-19 to investigate the association between multimorbidity and risk of severe SARS-CoV-2 infection.

Methods We used data from the UK Biobank linked to laboratory confirmed test results for SARS-CoV-2 infection and mortality data from Public Health England between March 16 and July 26, 2020. By reviewing the current literature on COVID-19 we derived a multimorbidity index including: 1) angina; 2) asthma; 3) atrial fibrillation; 4) cancer; 5) chronic kidney disease; 6) chronic obstructive pulmonary disease; 7) diabetes mellitus; 8) heart failure; 9) hypertension; 10) myocardial infarction; 11) peripheral vascular disease; 12) stroke. Adjusted logistic regression models were used to assess the association between multimorbidity and risk of severe SARS-CoV-2 infection (hospitalisation or death). Potential effect modifiers of the association were assessed: age, sex, ethnicity, deprivation, smoking status, body mass index, air pollution, 25‐hydroxyvitamin D, cardiorespiratory fitness, high sensitivity C-reactive protein.

Results Among 360,283 participants, the median age was 68 [range, 48-85] years, most were White (94.5%), and 1,706 had severe SARS-CoV-2 infection. The prevalence of multimorbidity was more than double in those with severe SARS-CoV-2 infection (25%) compared to those without (11%), and clusters of several multimorbidities were more common in those with severe SARS-CoV-2 infection. The most common clusters with severe SARS-CoV-2 infection were stroke with hypertension (79% of those with stroke had hypertension); diabetes and hypertension (72%); and chronic kidney disease and hypertension (68%). Multimorbidity was independently associated with a greater risk of severe SARS-CoV-2 infection (adjusted odds ratio 1.91 [95% confidence interval 1.70, 2.15] compared to no multimorbidity). The risk remained consistent across potential effect modifiers, except for greater risk among men.

Conclusion The risk of severe SARS-CoV-2 infection is higher in individuals with multimorbidity, indicating the need to target research and resources in people with SARS-CoV-2 infection and multimorbidity.

Competing Interest Statement

KK is chair for SAGE subgroup on ethnicity and COVID-19 and an independent member of SAGE.

Clinical Trial

Application Number: 36371

Funding Statement

This research was funded by the National Institute for Health Research (NIHR) Applied Research Collaboration East Midlands (ARC EM), and the NIHR Leicester Biomedical Research Centre, and a grant from the UKRI-DHSC COVID-19 Rapid Response Rolling Call (MR/V020536/1). NGF acknowledges funding from the MRC Epidemiology Unit core support (MC_UU_12015/5), and NIHR Biomedical Research Centre Cambridge: Nutrition, Diet, and Lifestyle Research Theme (IS-BRC-1215-20014).The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All participants gave written informed consent prior data collection. UK Biobank has full ethical approval from the NHS National Research Ethics Service (16/NW/0274).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵* Joint senior authors

  • yc244{at}leicester.ac.uk

  • fz43{at}leicester.ac.uk

  • clg13{at}leicester.ac.uk

  • cr288{at}leicester.ac.uk

  • ty20{at}leicester.ac.uk

  • dk261{at}leicester.ac.uk

  • alex.rowlands{at}leicester.ac.uk

  • melanie.davies{at}uhl-tr.nhs.uk

  • nazrul.Islam{at}ndph.ox.ac.uk

  • sis11{at}leicester.ac.uk

  • nita.forouhi{at}mrc-epid.cam.ac.uk

  • kk22{at}leicester.ac.uk

Data Availability

The data that support the findings of this study are available from UK Biobank project site, subject to registration and application process. Further details can be found at https://www.ukbiobank.ac.uk. Data on patients with COVID-19 is from an updated database which has not been reported in other submissions. The UK Biobank protocol https://www.ukbiobank.ac.uk/wp-content/uploads/2011/11/UK-Biobank-Protocol.pdf The statistical codes are available at GitHub yc244. https://github.com/yc244/Patterns-of-Multimorbidity-and-Risk-of-Severe-SARS-CoV-2-Infection-

https://www.ukbiobank.ac.uk

https://www.ukbiobank.ac.uk/wp-content/uploads/2011/11/UK-Biobank-Protocol.pdf

https://github.com/yc244/Patterns-of-Multimorbidity-and-Risk-of-Severe-SARS-CoV-2-Infection-

  • List of Abbreviations

    BMI
    Body mass index
    CI
    Confidence intervals
    CKD
    Chronic kidney disease
    COPD
    Chronic obstructive pulmonary disease
    CRP
    C-reactive protein
    eGFR
    Estimated Glomerular Filtration Rate
    IQR
    Interquartile range
    NHS
    National Health Service
    OR
    Odds ratio
    RR
    Relative risk
    UK
    United Kingdom
    WHO
    World Health Organization
    25(OH)D
    25-hydroxyvitamin D
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted October 23, 2020.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Patterns of Multimorbidity and Risk of Severe SARS-CoV-2 Infection: an observational study in the U.K
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Patterns of Multimorbidity and Risk of Severe SARS-CoV-2 Infection: an observational study in the U.K
    Yogini V Chudasama, Francesco Zaccardi, Clare L Gillies, Cameron Razieh, Thomas Yates, David E Kloecker, Alex V Rowlands, Melanie J Davies, Nazrul Islam, Samuel Seidu, Nita G Forouhi, Kamlesh Khunti
    medRxiv 2020.10.21.20216721; doi: https://doi.org/10.1101/2020.10.21.20216721
    Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Patterns of Multimorbidity and Risk of Severe SARS-CoV-2 Infection: an observational study in the U.K
    Yogini V Chudasama, Francesco Zaccardi, Clare L Gillies, Cameron Razieh, Thomas Yates, David E Kloecker, Alex V Rowlands, Melanie J Davies, Nazrul Islam, Samuel Seidu, Nita G Forouhi, Kamlesh Khunti
    medRxiv 2020.10.21.20216721; doi: https://doi.org/10.1101/2020.10.21.20216721

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Epidemiology
    Subject Areas
    All Articles
    • Addiction Medicine (230)
    • Allergy and Immunology (507)
    • Anesthesia (111)
    • Cardiovascular Medicine (1262)
    • Dentistry and Oral Medicine (207)
    • Dermatology (148)
    • Emergency Medicine (283)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (538)
    • Epidemiology (10055)
    • Forensic Medicine (5)
    • Gastroenterology (502)
    • Genetic and Genomic Medicine (2486)
    • Geriatric Medicine (240)
    • Health Economics (482)
    • Health Informatics (1653)
    • Health Policy (757)
    • Health Systems and Quality Improvement (638)
    • Hematology (250)
    • HIV/AIDS (538)
    • Infectious Diseases (except HIV/AIDS) (11896)
    • Intensive Care and Critical Care Medicine (627)
    • Medical Education (255)
    • Medical Ethics (75)
    • Nephrology (269)
    • Neurology (2304)
    • Nursing (140)
    • Nutrition (354)
    • Obstetrics and Gynecology (458)
    • Occupational and Environmental Health (537)
    • Oncology (1259)
    • Ophthalmology (377)
    • Orthopedics (134)
    • Otolaryngology (226)
    • Pain Medicine (158)
    • Palliative Medicine (50)
    • Pathology (326)
    • Pediatrics (737)
    • Pharmacology and Therapeutics (315)
    • Primary Care Research (282)
    • Psychiatry and Clinical Psychology (2295)
    • Public and Global Health (4850)
    • Radiology and Imaging (846)
    • Rehabilitation Medicine and Physical Therapy (493)
    • Respiratory Medicine (657)
    • Rheumatology (289)
    • Sexual and Reproductive Health (241)
    • Sports Medicine (228)
    • Surgery (273)
    • Toxicology (44)
    • Transplantation (131)
    • Urology (100)